Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003–2011

2013

DiScala, 1998, Injuries to children with attention deficit hyperactivity disorder, Pediatrics, 102, 1415, 10.1542/peds.102.6.1415

Hoare, 2003, Children with attention deficit hyperactivity disorder and attendance at hospital, Eur J Emerg Med, 10, 98, 10.1097/00063110-200306000-00005

Merrill, 2009, Attention deficit hyperactivity disorder and increased risk of injury, Adv Med Sci, 54, 20, 10.2478/v10039-009-0022-7

Pastor, 2006, Identified attention-deficit/hyperactivity disorder and medically attended, nonfatal injuries: US school-age children, 1997-2002, Ambul Pediatr, 6, 38, 10.1016/j.ambp.2005.07.002

Schwebel, 2011, Association of externalizing behavior disorder symptoms and injury among fifth graders, Acad Pediatr, 11, 427, 10.1016/j.acap.2011.03.003

Loe, 2007, Academic and educational outcomes of children with ADHD, J Pediatr Psychol, 32, 643, 10.1093/jpepsy/jsl054

Barbaresi, 2013, Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study, Pediatrics, 131, 637, 10.1542/peds.2012-2354

2007, Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry, 46, 894, 10.1097/chi.0b013e318054e724

2011, ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents, Pediatrics, 128, 1007, 10.1542/peds.2011-2654

1999, A 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder, Arch Gen Psychiatry, 56, 1073, 10.1001/archpsyc.56.12.1073

2004, National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder, Pediatrics, 113, 754, 10.1542/peds.113.4.754

Pelham, 2008, Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder, J Clin Child Adolesc Psychol, 37, 184, 10.1080/15374410701818681

Charach, 2011

Cooper, 2011, ADHD drugs and serious cardiovascular events in children and young adults, N Engl J Med, 365, 1896, 10.1056/NEJMoa1110212

Witt, 2008, Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD, J Am Acad Child Adolesc Psychiatry, 47, 1375, 10.1097/CHI.0b013e3181893620

Gould, 2009, Sudden death and use of stimulant medications in youths, Am J Psychiatry, 166, 992, 10.1176/appi.ajp.2009.09040472

U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) (formerly AERS). 2013. Available at: http://go.usa.gov/2Gc4. Accessed March 25, 2013.

Getahun, 2013, Recent trends in childhood attention-deficit/hyperactivity disorder, JAMA Pediatr, 167, 282, 10.1001/2013.jamapediatrics.401

Garfield, 2012, Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010, Acad Pediatr, 12, 110, 10.1016/j.acap.2012.01.003

Wolraich ML, McKeown RE, Visser SN, et al. The prevalence of ADHD: its diagnosis and treatment in four school districts across two states [published online ahead of print on September 12, 2012]. J Atten Disord. http://dx.doi.org/10.1177/1087054712453169.

Merikangas, 2010, Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A), J Am Acad Child Adolesc Psychiatry, 49, 980, 10.1016/j.jaac.2010.05.017

Centers for Disease Control and Prevention. National Center for Health Statistics, National Health Interview Survey. 2012. Available at: http://www.cdc.gov/nchs/nhis.htm. Accessed March 6, 2012.

Blumberg, 2009

Blumberg, 2005

Boyle, 2011, Trends in the prevalence of developmental disabilities in US children, 1997-2008, Pediatrics, 127, 1034, 10.1542/peds.2010-2989

Akinbami, 2011

2010, Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children—United States, 2003 and 2007, MMWR Morbid Mortal Wkly Rep, 59, 1439

Zuvekas, 2012, Stimulant medication use in children: a 12-year perspective, Am J Psychiatry, 169, 160, 10.1176/appi.ajp.2011.11030387

Centers for Disease Control and Prevention National Center for Health Statistics State and Local Area Integrated Telephone Survey. 2011–2012 National Survey of Children’s Health frequently asked questions. 2013. Available at: http://www.cdc.gov/nchs/slaits/nsch.htm. Accessed October 17, 2013.

Smith, 2005, Statistical methodology of the National Immunization Survey, 1994–2002, Vital Health Stat, 2, 1

2005, Prevalence of diagnosis and medication treatment for ADHD—United States, 2003, MMWR Morbid Mortal Wkly Rep, 54, 842

Visser, 2013, Convergent validity of parent-reported ADHD diagnosis: a cross-study comparison, JAMA Pediatr, 167, 674, 10.1001/jamapediatrics.2013.2364

Fulton, 2009, National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies, Psychiatr Serv, 60, 1075, 10.1176/ps.2009.60.8.1075

Stevens, 2004, Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder, J Dev Behav Pediatr, 25, 318, 10.1097/00004703-200410000-00003

Hillemeier, 2007, Racial differences in parental reports of attention-deficit/hyperactivity disorder behaviors, J Dev Behav Pediatr, 28, 353, 10.1097/DBP.0b013e31811ff8b8

Dempster, 2013, The role of stigma in parental help-seeking for child behavior problems, J Clin Child Adolesc Psychol, 42, 56, 10.1080/15374416.2012.700504

Molina, 2009, MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry, 48, 484, 10.1097/CHI.0b013e31819c23d0

Merikangas, 2011, Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey–Adolescent Supplement (NCS-A), J Am Acad Child Adolesc Psychiatry, 50, 32, 10.1016/j.jaac.2010.10.006

Hart, 2012, Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD), Neurosci Biobehav Rev, 36, 2248, 10.1016/j.neubiorev.2012.08.003

Harty, 2011, The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood, J Child Adolesc Psychopharmacol, 21, 331, 10.1089/cap.2010.0074

Molina, 2013, Adolescent substance use in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication, J Am Acad Child Adolesc Psychiatry, 52, 250, 10.1016/j.jaac.2012.12.014

Groenman, 2013, Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder, Br J Psychiatr, 203, 112, 10.1192/bjp.bp.112.124784

Humphreys, 2013, Stimulant medication and substance use outcomes: a meta-analysis, JAMA Psychiatry, 70, 740, 10.1001/jamapsychiatry.2013.1273

Kornfield, 2013, Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008, Psychiatr Serv, 64, 339, 10.1176/appi.ps.201200147

U.S. Food and Drug Administration. Communication about an ongoing safety review of stimulant medications used in children with attention-deficit/hyperactivity disorder (ADHD). 2011. Available at: http://go.usa.gov/2GcP Accessed March 15, 2013.

Barry, 2012, ADHD medication use following FDA risk warnings, J Ment Health Policy Econ, 15, 119

Du, 2012, Atomoxetine use during a period of FDA actions, Med Care, 50, 987, 10.1097/MLR.0b013e31826c86f1

Chai, 2012, Trends of outpatient prescription drug utilization in US children, 2002–2010, Pediatrics, 130, 23, 10.1542/peds.2011-2879

Comer, 2010, National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007, J Am Acad Child Adolesc Psychiatry, 49, 1001, 10.1016/j.jaac.2010.07.007

Olfson, 2010, Trends in antipsychotic drug use by very young, privately insured children, J Am Acad Child Adolesc Psychiatry, 49, 13

Harris G. F.D.A. finds short supply of attention deficit drugs. New York Times. January 1, 2012.

U.S. Food and Drug Administration. FDA works to lessen drug shortage impact. 2011. Available at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm258152.htm. Accessed March 25, 2013.

Graf, 2013, Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications, Neurology, 80, 1251, 10.1212/WNL.0b013e318289703b

2013

2008, Prescription for disaster: how teens abuse medicine, Drug Enforcement Administration

Doshi, 2012, Economic Impact of Childhood and Adult Attention-Deficit/Hyperactivity Disorder in the United States, J Am Acad Child Adolesc Psychiatry, 51, 990, 10.1016/j.jaac.2012.07.008